Brisbane Clinical Trials
The Crossover Study
The study drug is a potential new vaccine for COVID-19.
0 nights
2 vaccine visits, 1 phone call, 1 follow-up visits
- Study Objective:
- To explore the effects and safety of administering the COVID-19 vaccine alongside commonly used flu vaccines.
- The study focuses on the body's immune response to simultaneous vaccination against COVID-19 and influenza.
- Importance of Prevention:
- By potentially combining vaccines, the study aims to enhance public health measures and prevent the spread of both diseases.
- Clinical Trial Details:
- Approved by an ethics committee, the trial will compensate participants for their involvement and contribution to this important research.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Male or Female
Age 18 – 80 years old
BMI 18 – 35 kg/m²
Weight >50 kg
Medical History Certain stable medical conditions may be permitted
Medication Stable medications for 3+ months may be permitted
Smoking History Non-smokers or casual smokers (<10 cigarettes/week)